BioInvent International Balance Sheet Health
Financial Health criteria checks 6/6
BioInvent International has a total shareholder equity of SEK1.0B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK1.1B and SEK84.4M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 950.11m |
| Equity | SEK 1.00b |
| Total liabilities | SEK 84.38m |
| Total assets | SEK 1.09b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0H22's short term assets (SEK1.0B) exceed its short term liabilities (SEK76.1M).
Long Term Liabilities: 0H22's short term assets (SEK1.0B) exceed its long term liabilities (SEK8.3M).
Debt to Equity History and Analysis
Debt Level: 0H22 is debt free.
Reducing Debt: 0H22 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0H22 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0H22 has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 17.9% each year.